Investing.com - Financial Markets Worldwide

SCI Pharmtech Inc (4119)

Taiwan
Currency in TWD
64.80
-1.10(-1.67%)
Closed·
4119 Scorecard
Full Analysis
Has raised its dividend for 3 consecutive years
4119 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
64.8066.10
52 wk Range
61.8098.80
Key Statistics
Edit
Bid/Ask
87.00 / 87.10
Prev. Close
77.6
Open
66.1
Day's Range
64.8-66.1
52 wk Range
61.8-98.8
Volume
70.76K
Average Volume (3m)
123.21K
1-Year Change
-27.82%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4119 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Sell
Analysts Sentiment
Neutral
Price Target
90.00
Upside
+38.89%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 11
Trading at a low P/E ratio relative to near-term earnings growth
Unlock InvestingPro

SCI Pharmtech Inc Company Profile

SCI Pharmtech, Inc., together with its subsidiary, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals in Italy, the United States, Japan, Germany, Taiwan, Switzerland, China, and internationally. The company offers active pharmaceutical ingredients, including adenine, articaine HCl, atomoxetine HCl, bisoprolol hemifumarate, brinzolamide, buprenorphine and buprenorphine HCl, cannabidol, divalproex sodium, duloxetine HCl, hydroxychloroquine sulfate, loxoprofen sodium, methylphenidate HCl, pentobarbital sodium, pimobendan, probucol, propafenone HCI, sodium valproate, thiopental, and valproic acid; and develops benserazide, CBN, and CBD. It also provides intermediate products, such as diethyl isobutyl malonate, benzhydrylamine, 1-Benzhydrylazetidin-3-ol, azetidin-3-ol hydrogenchloride, 1-(2-hydroxyphenyl)-3-phenylpropan-1-one, ritalinic acid, d-ritalinic acid HCl, pyrogallol aldehyde, menthadienol, 5-pentylbenzene-1,3-diol olivetol, methyl 2,4-dihydroxy-6-pentylbenzoate, ethyl 2,4-dihydroxy-6-pentylbenzoate ethyl olivetolate, divarinol, lisdexamfetamine intermediate, UDP-GIcNAz, and UDP-GaINAz. In addition, the company offers customized production services. The company was incorporated in 1987 and is based in Taoyuan City, Taiwan.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
239
Market
Taiwan

Compare 4119 to Peers and Sector

Metrics to compare
4119
Peers
Sector
Relationship
P/E Ratio
15.1x0.0x−0.5x
PEG Ratio
0.190.000.00
Price/Book
1.4x0.0x2.6x
Price / LTM Sales
5.0x0.0x3.0x
Upside (Analyst Target)
36.6%0.0%49.2%
Fair Value Upside
Unlock0.0%7.4%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 90.00
(+38.89% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.37%
Dividend Yield
2.35%
Industry Median 2.40%
Annualised payout
1.50
Paid annually
5-Years Growth
-18.98%
Growth Streak
Unlock

Earnings

Latest Release
May 09, 2025
EPS / Forecast
0.26 / 0.26
Revenue / Forecast
370.00M / 370.00M
EPS Revisions
a
a
Unlock
Last 90 days

4119 Income Statement

FAQ

What Stock Exchange Does SCI Pharmtech Trade On?

SCI Pharmtech is listed and trades on the Taiwan Stock Exchange stock exchange.

What Is the Stock Symbol for SCI Pharmtech?

The stock symbol for SCI Pharmtech is "4119."

What Is the SCI Pharmtech Market Cap?

As of today, SCI Pharmtech market cap is 7.88B.

What Is SCI Pharmtech's Earnings Per Share (TTM)?

The SCI Pharmtech EPS (TTM) is 4.37.

When Is the Next SCI Pharmtech Earnings Date?

SCI Pharmtech will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is 4119 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has SCI Pharmtech Stock Split?

SCI Pharmtech has split 10 times.

How Many Employees Does SCI Pharmtech Have?

SCI Pharmtech has 239 employees.

What is the current trading status of SCI Pharmtech (4119)?

As of 08 Jul 2025, SCI Pharmtech (4119) is trading at a price of 64.80, with a previous close of 77.60. The stock has fluctuated within a day range of 64.80 to 66.10, while its 52-week range spans from 61.80 to 98.80.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.